オプションチェーンは、Park Ntlの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Park Ntlの市場センチメントを評価します。.

Park Ntl (AMEX:PRK) 株価情報, オプションチェーン

Park Ntl

Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. Park National provides banking and other financial services to consumers and businesses.

Park National Corp

PARKS! AMERICA INC by Parks! America, Inc.

Parks! America Inc

PARKER CORP by Parker Corp.

Perk International Inc

Parkervision Inc

United Parks & Resorts Inc

PARKVIDA GROUP INC by ParkVida Group, Inc.

ParkVida Group Inc

Parkway Life Real Estate Investment Trust

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Domino&#8217;s Pizza, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) to report quarterly earnings at $4.05 per share on revenue of $1.13 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Domino&#8217;s shares gained 0.5% to $490.00 in after-hours trading.</li>
<li>Analysts are expecting NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) to post quarterly earnings at $2.58 per share on revenue of $2.83 billion. The company will release earnings after the markets close. NXP Semiconductors shares fell 0.6% to $192.40 in after-hours trading.</li>
<li>Park National Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRK#NYSE">PRK</a>) posted better-than-expected earnings for its first quarter on Friday. Park National shares gained 1.6% to $150.15 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>After the markets close, Waste Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) is projected to post quarterly earnings at $1.62 per share on revenue of $6.12 billion. Waste Management shares rose 0.2% to $228.80 in after-hours trading.</li>
<li>Analysts expect Roper Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROP#NASDAQ">ROP</a>) to post quarterly earnings at $4.74 per share on revenue of $1.82 billion before the opening bell. Roper Technologies shares slipped 0.1% to $557.61 in the after-hours trading session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/45007118/top-2-health-care-stocks-that-may-crash-this-month">Top 2 Health Care Stocks That May Crash This Month</a> </li>
</ul>
Photo via Shutterstock

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

NXPI

Domino's Pizza, NXP Semiconductors And 3 Stocks To Watch Heading Into Monday

Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) reported quarterly earnings of $2.57 per share which beat the analyst consensus estimate of $2.15 by 19.53 percent. This is a 19.53 percent increase over earnings of $2.15 per share from the same period last year.

Earnings Beats

Park Ntl Q1 Adj. EPS $2.57 Beats $2.15 Estimate

U.S. stock futures trade mixed in a choppy session on Thursday night, amid President&nbsp;Donald Trump&#8217;s&nbsp;reassurance of a trade deal with Europe and China in the afternoon, following a fresh jab at Federal Reserve chair Jerome Powell for not cutting interest rates.
S&amp;P 500 futures are up 0.36% at 5,326, Nasdaq Futures up 0.23% at 18,427, followed by Dow Futures, down 1.14% at 39,398, owing to disappointing earnings results of a few components early in the day.
See More: <a href="https://www.benzinga.com/news/25/04/44880439/80-of-americans-say-the-country-would-be-better-off-with-more-manufacturing-jobs-but-only-25-want-one-themselves">80% Of Americans Say The Country Would Be Better Off With More Manufacturing Jobs—But Only 25% Want One Themselves</a>
Japan&#8217;s benchmark Nikkei 225 is up 0.39% after recovering from early losses, as investors interpret key inflation data, which came in at 3.6%, ahead of the Bank of Japan&#8217;s 2.0% target, but below February figures at 3.7%. Pharmaceuticals, auto, and shipping stocks lead the charge as trade talks with the U.S. gain steam.
The U.S. Dollar Index (DXY) pared its gains on Thursday and is now flat at 99.41, up 0.03% at the time of writing. This comes amid growing political pressure on the Federal Reserve to cut interest rates, with the President <a href="https://benzinga.com/markets/cryptocurrency/25/04/44861571/donald-trump-blasts-too-late-and-wrong-fed-chair-powell-but-polymarket-traders-doubt-his-termination-will-come-fast-enough">calling for Fed Chair Powell&#8217;s</a> &#8220;Termination.&#8221;
The U.S. markets are closed on Friday for Good Friday.
Photo Courtesy: Goodvibes Photo on Shutterstock.com
Read More: <a href="https://www.benzinga.com/tech/25/04/44878856/bank-of-america-bets-big-on-ai-with-4-billion-investment-and-its-already-paying-off">Bank Of America Bets Big On AI With $4 Billion Investment—And It&#8217;s Already Paying Off</a>

US Futures Mixed, Nikkei Opens Lower As Investors Digest Inflation Data — Dollar Slides As Trump Takes Fresh Jab At Fed's Powell

Keefe, Bruyette &amp; Woods analyst Damon Delmonte reiterates Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) with a Market Perform and lowers the price target from $187 to $178.

Price Target

Reiteration

Analyst Ratings

Keefe, Bruyette & Woods Reiterates Market Perform on Park Ntl, Lowers Price Target to $178

WIIM

Park National shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results.

Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) just disclosed its Q4 earnings on Monday, January 27, 2025 at 04:15 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Park Ntl beat estimated earnings by 5.0%, reporting an EPS of $2.35 versus an estimate of $2.24.
Revenue was up $23.92 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
In the previous quarter, the company missed on EPS by $0.04, resulting in a 4.0% increase change in the share price the following day.
Here's a look at Park Ntl's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.29</td>
<td>2</td>
<td>1.83</td>
<td>1.71</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.25</td>
<td>2.38</td>
<td>2.15</td>
<td>2</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>127.78M</td>
<td>120.55M</td>
<td>117.41M</td>
<td>120.64M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>137.64M</td>
<td>126.63M</td>
<td>121.82M</td>
<td>110.59M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Park Ntl <a href="https://www.benzinga.com/quote/PRK/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Breakdown: Park Ntl Q4

Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) reported quarterly earnings of $2.35 per share which beat the analyst consensus estimate of $2.25 by 4.44 percent. This is a 17.5 percent increase over earnings of $2.00 per share from the same period last year.

Park Ntl Q4 Adj $2.35 Beats $2.25 Estimate

Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) reported quarterly earnings of $2.25 per share which missed the analyst consensus estimate of $2.29 by 1.75 percent. This is a 1.32 percent decrease over earnings of $2.28 per share from the same period last year.

Earnings Misses

Park Ntl Q3 Adj $2.25 Misses $2.29 Estimate

Park National shares are trading higher after the company reported better-than-expected Q2 EPS results.

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Tuesday.
Shares of Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) rose sharply during Tuesday's session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/07/39907956/life-science-giant-danahers-q2-earnings-beat-estimates-on-sustained-positive-momentum-in-bioprocess">second quarter earnings</a>.
Danaher's second quarter sales decreased 3% year-over-year to $5.743 billion, beating the consensus of $5.59 billion. Danaher reported second-quarter adjusted EPS of $1.72, beating the consensus of $1.57, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
Danaher shares gained 7.4% to $269.35 on Tuesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Kiniksa Pharmaceuticals International, plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) shares jumped 16% to $24.81 after the company reported better-than-expected second-quarter sales results and raised its FY24 net product revenue guidance.</li>
<li>Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) gained 12.7% to $333.02 following second-quarter earnings.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) surged 11.8% to $12.34.</li>
<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) gained 11.8% to $6.90.</li>
<li>KKR Real Estate Finance Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KREF#NYSE">KREF</a>) surged 11.2% to $11.22 following second-quarter results.</li>
<li>MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) shares jumped 11.1% to $561.96 following better-than-expected second-quarter financial results.</li>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) gained 10.3% to $66.27.</li>
<li>Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) gained 9% to $29.48. HC Wainwright &amp; Co. analyst Patrick Trucchio initiated coverage on Beam Therapeutics with a Buy rating and announced a price target of $80.</li>
<li>Iridium Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>) rose 8.5% to $28.11 after the company reported better-than-expected second-quarter EPS results.</li>
<li>Crown Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) gained 8.5% to $84.04 after the company reported better-than-expected second-quarter earnings and raised its FY24 EPS guidance above estimates.</li>
<li>MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) climbed 8% to $96.75 following better-than-expected quarterly earnings.</li>
<li>Inter Parfums, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) gained 8% to $137.34 after the company reported better-than-expected expected sales.</li>
<li>Owens &amp; Minor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>) rose 8% to $16.51 as the company released preliminary second quarter 2024 financial results and signed a definitive agreement to acquire Rotech Healthcare for $1.36 billion in cash.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) shares gained 8% to $8.15. Mesoblast recently started enrollment in Phase 3 trial of Rexlemestrocel-L for chronic low back pain.</li>
<li>Pentair plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) gained 7.7% to $86.19 after the company reported better-than-expected second quarter financial results and revised its FY24 adjusted EPS guidance above estimates.</li>
<li>Park National Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRK#NYSE">PRK</a>) gained 7.4% to $182.78 following upbeat quarterly earnings.</li>
<li>Wheels Up Experience Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) gained 7.1% to $3.46.</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) shares surged 6.4% to $173.21 after the company reported better-than-expected second quarter adjusted EPS and raised its FY24 outlook.</li>
<li>SAP SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) gained 6% to $0.2390 after the company reported second-quarter financial results.</li>
<li>Hims &amp; Hers Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NASDAQ">HIMS</a>) gained 5.6% to $21.51.</li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) surged 5.5% to $178.95.</li>
<li>Zions Bancorporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) rose 5.4% to $52.12 after posting better-than-expected quarterly results on Monday.</li>
<li>Brown &amp; Brown, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) gained 5.2% to $97.99 following upbeat quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39907046/best-buy-kroger-and-2-other-stocks-insiders-are-selling">Best Buy, Kroger And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

Intraday Update

Movers

BEAM

Hims & Hers Health, Inc. Class A Common Stock

HIMS

IPAR

IRDM

KNSA

KREF

MESO

MMYT

MSCI

SPOT

ZION

Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday

Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) reported quarterly earnings of $2.42 per share which beat the analyst consensus estimate of $2.00 by 21 percent. This is a 24.74 percent increase over earnings of $1.94 per share from the same period last year.

Park Ntl Q2 Adj $2.42 Beats $2.00 Estimate

Keefe, Bruyette &amp; Woods analyst Damon Delmonte reiterates Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) with a Market Perform and raises the price target from $125 to $130.

Keefe, Bruyette & Woods Reiterates Market Perform on Park Ntl, Raises Price Target to $130

Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) reported quarterly earnings of $2.17 per share which beat the analyst consensus estimate of $1.83 by 18.58 percent.

Park Ntl Q1 2024 GAAP EPS $2.17 Beats $1.83 Estimate

Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) reported quarterly earnings of $2.00 per share which beat the analyst consensus estimate of $1.71 by 16.96 percent. This is a 0.99 percent decrease over earnings of $2.02 per share from the same period last year.

Park Ntl Q4 EPS $2.00 Beats $1.71 Estimate

Park Ntl Q3 EPS $2.28

Keefe, Bruyette &amp; Woods maintains Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) with a Market Perform and lowers the price target from $109 to $108.

Keefe, Bruyette & Woods Maintains Market Perform on Park Ntl, Lowers Price Target to $108

<h1>&nbsp;</h1>
On Tuesday, 56 companies set new 52-week lows.
<h2>Noteworthy Highlights From Today&#39;s 52-Week Lows:</h2>
<ul>
<li>The largest company by market cap to set a new 52-week low was Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>).</li>
<li>9 Meters Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTR#NASDAQ">NMTR</a>) was the smallest company by market cap to set a new 52-week low.</li>
<li>Humanigen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGEN#NASDAQ">HGEN</a>)&#39;s stock came under the most pressure, trading down 73.22% to reach a new 52-week low.</li>
<li>NeuBase Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBSE#NASDAQ">NBSE</a>) saw the biggest bounce back on, as shares traded up 0.0% to rebound after it hit its new 52-week low.</li>
</ul>
On Tuesday, the following stocks set new 52-week lows:
<ul>
<li>Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) stock drifted down 2.25% on Tuesday morning to hit a new 52-week low of $31.23.</li>
<li>Silicon Motion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIMO#NASDAQ">SIMO</a>) stock hit a new 52-week low of $51.44. The stock was down 1.3% on the session.</li>
<li>Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) stock dropped to a yearly low on Tuesday of $90.28. Shares traded down 6.01%.</li>
<li>Avidity Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) stock hit $9.29 on Tuesday morning, setting a new 52-week low for a change of down 3.79%.</li>
<li>IDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDT#NYSE">IDT</a>) stock set a new 52-week low of $23.08 on Tuesday, moving down 0.98%.</li>
<li>Vertex Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTNR#NASDAQ">VTNR</a>) shares hit a yearly low of $5.11. The stock was down 21.54% on the session.</li>
<li>uniQure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QURE#NASDAQ">QURE</a>) shares fell to $9.64 on Tuesday, setting a new 52-week low with a shift of down 0.1%.</li>
<li>TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) stock set a new 52-week low of $13.52 on Tuesday, moving down 20.83%.</li>
<li>PSQ Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSQH#NYSE">PSQH</a>) shares set a new 52-week low of $15.51. The stock traded down 5.28%.</li>
<li>Erasca (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERAS#NASDAQ">ERAS</a>) stock drifted down 3.28% on Tuesday morning to hit a new 52-week low of $2.46.</li>
<li>Rimini Street (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMNI#NASDAQ">RMNI</a>) shares moved down 31.95% on Tuesday to hit a new 52-week low of $3.21, drifting down 31.95%.</li>
<li>Stoke Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) shares hit a yearly low of $6.17. The stock was down 33.68% on the session.</li>
<li>NGM Biopharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGM#NASDAQ">NGM</a>) stock hit $2.38 on Tuesday morning, setting a new 52-week low for a change of down 4.4%.</li>
<li>Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) stock hit a new 52-week low of $8.22. The stock was up 1.09% on the session.</li>
<li>Kezar Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZR#NASDAQ">KZR</a>) stock set a new 52-week low of $2.21 on Tuesday, moving down 0.44%.</li>
<li>Altimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) shares fell to $3.02 on Tuesday, setting a new 52-week low with a shift of down 1.25%.</li>
<li>Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) stock broke to a new 52-week low of $3.53 on Tuesday. Shares of the company traded down 3.27%.</li>
<li>ADC Therapeutics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADCT#NYSE">ADCT</a>) shares set a new 52-week low of $1.22. The stock traded up 0.3%.</li>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) shares set a new 52-week low of $1.72. The stock traded down 5.88%.</li>
<li>Airgain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>) shares were down 2.91% for the day, having made a 52-week low of $4.62.</li>
<li>Destra Multi-Alternative (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DMA#NYSE">DMA</a>) shares fell to $4.78 on Tuesday, setting a new 52-week low with a shift of down 0.41%.</li>
<li>CBL International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BANL#NASDAQ">BANL</a>) shares hit a yearly low of $1.64. The stock was down 12.18% on the session.</li>
<li>Eledon Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELDN#NASDAQ">ELDN</a>) shares hit a yearly low of $1.26. The stock was down 1.54% on the session.</li>
<li>Purple Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBT#NASDAQ">PPBT</a>) shares reached a new 52-week low of $1.17 on Tuesday morning, moving up 0.13%.</li>
<li>Vaccinex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCNX#NASDAQ">VCNX</a>) stock set a new 52-week low of $0.28 on Tuesday, moving down 1.49%.</li>
<li>Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) shares set a new 52-week low of $0.53. The stock traded down 4.2%.</li>
<li>AERWINS Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWIN#NASDAQ">AWIN</a>) shares set a new yearly low of $0.22 this morning. The stock was down 3.94% on the session.</li>
<li>Cadrenal Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVKD#NASDAQ">CVKD</a>) shares set a new yearly low of $1.01 this morning. The stock was down 3.62% on the session.</li>
<li>Greenbrook TMS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBNH#NASDAQ">GBNH</a>) shares set a new 52-week low of $0.30. The stock traded down 8.88%.</li>
<li>60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) shares set a new yearly low of $2.13 this morning. The stock was down 7.23% on the session.</li>
<li>BioRestorative Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRTX#NASDAQ">BRTX</a>) shares were down 9.4% for the day, having made a 52-week low of $2.33.</li>
<li>Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) stock achieved a new 52-week low on Tuesday morning, hitting $0.96 and moving down 7.87%.</li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) stock hit $0.51 on Tuesday morning, setting a new 52-week low for a change of up 0.37%.</li>
<li>Cyclerion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) stock dropped to a yearly low on Tuesday of $3.19. Shares traded down 4.14%.</li>
<li>Lixte Biotech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) shares made a new 52-week low of $3.82 on Tuesday. The stock was down 1.53% for the day.</li>
<li>Cingulate (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CING#NASDAQ">CING</a>) stock broke to a new 52-week low of $0.60 on Tuesday. Shares of the company traded down 15.06%.</li>
<li>ViewRay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAY#NASDAQ">VRAY</a>) stock achieved a new 52-week low on Tuesday morning, hitting $0.03 and moving down 10.58%.</li>
<li>Humanigen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGEN#NASDAQ">HGEN</a>) stock drifted down 73.22% on Tuesday morning to hit a new 52-week low of $0.05.</li>
<li>Mallinckrodt (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MNK#AMEX">MNK</a>) shares moved down 0.96% on Tuesday to hit a new 52-week low of $0.43, drifting down 0.96%.</li>
<li>Aceragen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGN#NASDAQ">ACGN</a>) stock drifted down 7.38% on Tuesday morning to hit a new 52-week low of $0.66.</li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock drifted down 1.55% on Tuesday morning to hit a new 52-week low of $0.60.</li>
<li>SuperCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCB#NASDAQ">SPCB</a>) shares hit a yearly low of $0.76. The stock was up 0.89% on the session.</li>
<li>C3is (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISS#NASDAQ">CISS</a>) stock hit $0.63 on Tuesday morning, setting a new 52-week low for a change of down 3.16%.</li>
<li>Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) stock broke to a new 52-week low of $0.22 on Tuesday. Shares of the company traded down 10.06%.</li>
<li>NeuBase Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBSE#NASDAQ">NBSE</a>) stock drifted 0.0% (flat) on Tuesday morning to hit a new 52-week low of $1.50.</li>
<li>Altamira Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTO#NASDAQ">CYTO</a>) shares fell to $0.33 on Tuesday, setting a new 52-week low with a shift of down 0.75%.</li>
<li>BitNile Metaverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNMV#NASDAQ">BNMV</a>) shares hit a yearly low of $0.90. The stock was down 2.92% on the session.</li>
<li>Esports Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMBL#NASDAQ">GMBL</a>) stock hit a yearly low of $0.51. The stock was down 4.04% for the day.</li>
<li>9 Meters Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTR#NASDAQ">NMTR</a>) shares moved down 14.45% on Tuesday to hit a new 52-week low of $0.10, drifting down 14.45%.</li>
</ul>
Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. <a href="https://pro.benzinga.com/?afmc=2a&amp;utm_source=benzinga.com&amp;utm_medium=web&amp;utm_campaign=premium_products">Click here to learn more</a>.

Options

ACGN

ADCT

AIRG

APLS

AVTX

AWIN

BANL

BNMV

BPTH

BRTX

CING

CISS

CVKD

CYCN

CYTO

ELDN

ERAS

GBNH

GMBL

GOVX

HGEN

INGN

LIXT

NBSE

NMTR

PPBT

PSQH

QURE

RMNI

SIMO

SNGX

SPCB

STOK

SXTP

TTNP

VCNX

VRAY

VTNR

XAIR

Stocks That Hit 52-Week Lows On Tuesday

Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) reported quarterly earnings of $1.94 per share which missed the analyst consensus estimate of $1.97 by 1.52 percent. This is a 7.62 percent decrease over earnings of $2.10 per share from the same period last year.

Park Ntl Q2 EPS $1.94 Misses $1.97 Estimate

Piper Sandler analyst Scott Siefers downgrades Park Ntl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PRK#AMEX">PRK</a>) from Neutral to Underweight and lowers the price target from $115 to $103.

Downgrades

Piper Sandler Downgrades Park Ntl to Underweight, Lowers Price Target to $103

Park Aerospace Corp. (NYSE-PKE) announced that, on April 5, 2023, the Company&#39;s largest customer qualified and fully approved the Company&#39;s major expansion of its Newton, Kansas facilities for production on all of the customer&#39;s aircraft programs. Park further announced that its first manufacturing production run in the Company&#39;s major expansion facilities occurred on April 19, 2023. 
&nbsp;
The major expansion, which was designed as a redundant facility to support critical aircraft programs on which the Company is sole source qualified, was originally announced in December of 2018. The expansion, which consists of approximately 90,000 square feet of additional manufacturing, laboratory and office space, approximately doubled the size of the preexisting footprint of the Company&#39;s Newton, Kansas facilities. The expansion cost approximately&nbsp;$20 million.
Brian Shore, Park&#39;s Chairman and CEO, said, &quot;We broke ground on our major expansion on August 15, 2019. It was a typical windy and hot summer day in Kansas. I remember having to hold down the tent as I was giving a little speech at the groundbreaking event. Of course, when we broke ground, we had no idea that the global pandemic was looming around the corner. The pandemic posed its share of challenges in the construction of the facility and the installation of the complex equipment contained in the facility, no doubt. But, while many others were slashing their capital spending or cancelling their capital projects altogether, we pushed forward with all we had and completed our major expansion project and never looked back.&quot;
Brian Shore continued, &quot;And there is more to this story which should be told. Our Great Production People have been working 60 hour or more weeks on a regular basis for quite a while, and, as a result, did not have the additional bandwidth required to staff the extensive manufacturing trials and qualification runs necessary to qualify the facility&#39;s complex new equipment lines for the aerospace programs they are intended to support. So, in order to avoid delays in the qualification of our new facility and equipment, our Great R&amp;D and Engineering People stepped up and staffed the manufacturing trials and qualification runs. They are staffing early production as well. And I do not recall anybody asking our R&amp;D and Engineering People to do these things. They just did them. Thank you, R&amp;D and Engineering People, for your dedication and loyalty. We are very fortunate at Park to have the wonderful People we have.&quot;
Brian Shore concluded, &quot;The qualification and approval, by our largest customer, of our new redundant facility, and the commencement of production in the new facility, are big milestones for us. It has been a long and challenging road since we broke ground on that hot and windy summer day in August of 2019. Thanks to the dedication of our special Park People, that road has been traversed and our new redundant facility is in production.&quot;

Park Aerospace Corp. Announces Its Largest Customer Has Approved And Qualified The Company's Major Expansion For Production

Management

Press Releases

Park National Corporation welcomes Kelly Gratz and Karen Morrison to Board of Directors

Park National Corporation reports financial results for second quarter and first half of 2024

Park National Corporation reports financial results for third quarter and first nine months of 2024

Comments

Park Ntl

Park Ntl (PRK) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル